Amarantus Bioscience Holdings Inc - ESG Rating & Company Profile powered by AI
This report of Amarantus Bioscience Holdings Inc leverages information from across the web as well as from public disclosures by Amarantus Bioscience Holdings Inc. Comprehensive ESG analysis of Amarantus Bioscience Holdings Inc can be reached by signing up for free. Alternative companies in the scoring industry group for Amarantus Bioscience Holdings Inc are displayed below.
Amarantus Bioscience Holdings Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Amarantus Bioscience Holdings Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Amarantus Bioscience Holdings Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc report the average age of the workforce?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc offer flexible work?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc conduct supply chain audits?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose water use targets?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Amarantus Bioscience Holdings Inc have a product recall in the last two years?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Amarantus Bioscience Holdings Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose parental leave metrics?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Amarantus Bioscience Holdings Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose its waste policy?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc report according to TCFD requirements?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose energy use targets?
Sign up for free to unlockDoes Amarantus Bioscience Holdings Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Amarantus Bioscience Holdings Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Amarantus Bioscience Holdings Inc
These potential risks are based on the size, segment and geographies of the company.
Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company's diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer's disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with multiple sclerosis. Its therapeutic products in development comprise Eltoprazine, a small molecule drug for the treatment of Parkinson's disease Levadopa-Induced Dyskinesia and attention deficit hyperactivity disorders; and mesencephalic-astrocyte-derived neurotrophic factor for the treatment of various animal models, including retinitis pigmentosa and retinal artery occlusion. It also develops NuroPro, a neurodegenerative disease diagnostic platform with application in Parkinson's disease; BC-SeraPro, an oncology diagnostic platform with application in breast cancer; and PhenoGuard platform for neurrotrophic factor discovery. In addition, the company develops Engineered Skin Substitute (ESS), a cell therapy-based autologous skin replacement product that is in mid-stage clinical development for the treatment of life-threatening severe burns. Amarantus BioScience Holdings, Inc. has a cooperative research and development agreement with the U.S. Army Institute of Surgical Research and Rutgers University. The company was formerly known as Amarantus Bioscience, Inc. and changed its name to Amarantus BioScience Holdings, Inc. in April 2013. Amarantus BioScience Holdings, Inc. was founded in 2008 and is headquartered in New York, New York.